Serum interleukin-6 levels reflect disease status of gastric cancer

American Journal of Gastroenterology

Volumn 91, Issue 7, 1996, Pages 1417-1422

  Wu, C W ^a,b   Wang, S R ^a   Chao, M F ^a   Wu, T C ^a   Lui, W Y ^a   P'eng, F K ^a   Chi, C W ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 6; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRECTOMY; HEPATITIS B; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH LESION;

ADENOCARCINOMA; AGED; ANTIBODIES, BACTERIAL; CARCINOEMBRYONIC ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYPS; STOMACH NEOPLASMS; STOMACH ULCER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030061195     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hirano T, Akira S, Taga T, et al. Biological and clinical aspect of interleukin-6. Immunol Today 1990:11:443-9.
2. Kirnbauer R, Kock A, Schwarz T, et al. IFN-b2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cells. J Immunol 1989:142:1922-8.
3. Rawle FC, Shields J, Smith SH, et al. B cell growth and differentiation induced by supernatants of transformed epithelial cell lines. Eur J Immunol 1986:16:1017-9.
4. Miki S, Iwano M, Miki Y, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989:250:607-10.
5. Watson JM, Sensintaffar JL, Berek JS, et al. Constitutive production of IL-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990:50:6959-65.
6. Bataille R, Jourdan M, Zhang XG, et al. Serum levels of interleukin 6, a potent myeloma growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 1989:84:2008-11.
7. Tsukamoto T, Kumanoto Y, Miyao N, et al. Interleukin-6 in renal cell carcinoma. J Urol 1992:148:1778-82.
8. Seguchi T, Yokokawa K, Sugao H, et al. Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J Urol 1992:148:791-4.
9. Gallo O, Gori AM, Attanasio M, et al. Acute-phase proteins and interleukin-6 serum level in head and neck cancer. Arch Otolaryngol 1992:118:1366-7 (letter).
10. Berek JS, Chung C, Kaldi K, et al. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1991:164:1038-43.
11. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991:325: 1127-31.
12. Wu CW, Wang SR, Chien SL, et al. Regulation of arginase production by glucocorticoid in three human gastric cancer cell lines. Life Sci 1992:51:1355-61.
13. Jin LD, Meng CL, Han SH, et al. A study on production of monoclonal antibodies using SC-M1 cell as immunogen. Med Sci 1987:8:17-25.
14. Barranco SC, Townsend CM, Casartelli C, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 1983:43;1703-9..
15. Shimizu Y, Weidmann E, Iwatsuki S, et al. Characterization of human autotumor-reactive T cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 1991: 51:6153-62.
16. Johannsson A, Ellis SH, Bates DL, et al. Enzyme amplification for immunoassays: Detection limit of one hundredth of an attomole. J Immunol Methods 1986:87:7-11.
17. Martin KW, Halperm SE. Carcinoembryonic antigen production, and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res 1984:44:5475-81.
18. Identification system for Campylobacter. Instruction manual. Lyon, France, 1991.
19. Lin JT, Wang JT, Wang TH, et al. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma: A seroprevalence study in Taiwan. Scand J Gastroenterol 1993:28:1067-72.
20. Sterberg JC. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 1977:23:1456-64.
21. Japanese Research Society for Gastric cancer: The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 1981:11: 127-45.
22. Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma: An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965:64:31-49.
23. Ming SC. Gastric carcinoma. A pathological classification. Cancer 1977:39:2475-85.
24. Hermanek P, Sobin LH. TNM classification of malignant tumors. Geneva: International Union Against Cancer, 1992:45.
25. Motro B, Itin A, Sachs L, et al. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 1990:87:3092-96.
26. Tanner J, Tosato G. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 1991:88:239-47.
27. Wu CW, Chi CW, Ho CK, et al. Effect of arginase on splenic killer cell activity in patients with gastric cancer. Dig Dis Sci 1994:39: 1107-12.
28. Stadler WM, Richards JM, Vogelzang NJ. Serum interleukin-6 levels in metastatic renal cell cancer: Correlation with survival but not an inde-pendent prognostic indicator. J Natl Cancer Inst 1992:84:1835-6.
29. Shimizu N, Wakatsuki T, Murakami A, et al. Carcinoembryonic antigen in gastric cancer patients. Oncology 1987:44:240-4.
30. Nakane Y, Okamura S, Akehira K, et al. Correlation of preoperative Carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer 1994:73:2703-8.
31. Koga T, Kano T, Souda K, et al. The clinical usefulness of preoperative CEA determination in gastric cancer. Jpn J Surg 1987:17:342-7.
32. Janssen CW, Ørjasater H. Carcinoembryonic antigen in patients with gastric carcinoma. Eur J Surg Oncol 1986:12:19-23.
33. Ellis DJ, Speirs C, Kingston RD, et al. Carcinoembryonic antigen levels in advanced gastric carcinoma. Cancer 1978:42:623-5.
34. Gauldie J, Richards C, Harnish D, et al. Interferon beta 2/BSF2 shares identity with monocyte-derived hepatocyte stimulating factor and regulates the major acute phase protein in liver cells. Proc Natl Acad Sci USA 1987:84:7251-5.